| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a56e82e7ee8111cfcd7565412176b3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5ad7217d291e44b5bdf93db60feda79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e085f2e33dde909ef5f10eea301632d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_668e4c0a0d952606b65f33ab3a0802b1 |
| publicationDate |
2008-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2684562-A1 |
| titleOfInvention |
New use for cannabinoid-containing plant extracts |
| abstract |
The present invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of diseases or conditions that are alleviated by blockade of one or more types of TRP channel. Preferably the subset of TRP channel that is blockaded is the TRPA channel. More preferably the TRPA channel is the TRPA1 channel. Preferably the diseases or conditions to be prevented or treated include: neuropathic pain, inflammation or vasoconstriction. Alternatively the TRP channel that is blockaded is the TRPM channel. More preferably the TRPM channel is the TRPM8 channel. Preferably the diseases or conditions to be prevented or treated are cancer. More preferably the cancers to be treated include: cancer of the prostate, cancer of the breast, cancer of the colon, cancer of the lung or cancer of the skin. Alternatively the TRP channel that is blockaded is the TRPV channel. More preferably the TRPV channel is the TRPV1 channel. Preferably the diseases or conditions to be prevented or treated include neuropathic pain, inflammation or vasoconstriction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537592-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821147-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020000103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10383892-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143706-B2 |
| priorityDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |